Home › Primary Effusion Lymphoma
Primary Effusion Lymphoma clinical trials recruiting in the U.S.
5 studies for Primary Effusion Lymphoma are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06343311Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Sep 28, 2026 · NCT00006518Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
RecruitingPhase 2
Ages 18 to 120 · All sexes · Updated Sep 25, 2026 · NCT05907759Natural History of KSHV-Associated Multicentric Castleman s Disease
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT04968288Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05544019From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.